C. Knott

发表

Elucidating the Kinetics of Expression and Immune Cell Infiltration Resulting from Plasmid Gene Delivery Enhanced by Surface Dermal Electroporation

N. Sardesai, W. Kiosses, Gleb Kichaev, 2013, Vaccines.

Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?

N. Kay, L. Karavodin, C. Knott, 1994, Clinical and diagnostic laboratory immunology.

Benign prostate-specific antigen (BPSA) in serum is increased in benign prostate disease.

Leonard S Marks, L. Marks, Stephen D Mikolajczyk, 2003, Clinical chemistry.

BRCA1 partially reverses the transforming activity of the ras oncogene.

M. Saedi, C. Knott, K. Kuus-Reichel, 1999, Neoplasia.

Evaluation of Bcl-2/B cell transgenic mice (B6) for hybridoma production.

John Calvin Reed, M. Saedi, S. Bodrug, 1996, Hybridoma.

Production of IgG monoclonal antibodies to the tumor-associated antigen, CA-195.

C. Knott, A. Beebe, K. Kuus-Reichel, 1994, Hybridoma.

Therapy of streptozotocin induced diabetes with a bifunctional antibody that delivers vinca alkaloids to IL-2 receptor positive cells.

E. Petrella, C. Knott, J. Corvalan, 1995, Autoimmunity.

Human IL-6 enhances human lymphocyte engraftment and activation but not human antibody production in SCIDhu PBL mice.

C. Knott, M. Coccia, K. Kuus-Reichel, 1998, Immunobiology.

Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses

N. Sardesai, J. Kim, D. Weiner, 2012, Science Translational Medicine.

Isolation of hybridoma forming cells from immune spleens by unit gravity sedimentation.

C. Knott, A. Beebe, K. Kuus-Reichel, 1991, Hybridoma.

Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses

N. Sardesai, J. Kim, D. Weiner, 2012, Science Translational Medicine.